Sony eyes using image sensors for medical equipment; Should the FDA evaluate devices made with 3D printers?;

@FierceMedDev: "Brain window" implant could enable targeted treatments. Item | Follow @FierceMedDev

@MarkHFierce: bioMerieux's $450M BioFire Dx buy gives it an even greater foothold in infectious disease diagnostics. Story | Follow @MarkHFierce

> Women are 25% less likely than men to die one year after transcatheter aortic valve implantation (TAVI), according to new research presented at the ESC Congress 2013 in Amsterdam. Item

> Sony is looking at using its image sensors, in part, for new medical equipment. Story

> The FDA is looking at how it might evaluate medical devices made using 3D printers. Story

> Researchers at Brigham and Women's Hospital in Boston have developed a diagnostic risk score calculation that can help predict which patients are at risk of kidney failure or death after injury. Item

> Purview in Crofton, MD, is launching a new medical image storage and sharing platform--a cloud-based system designed to give patients more control over their medical records. Item

> Coherex Medical won a CE mark for its new left atrial appendage occlusion sytem, which is designed to help treat atrial fibrillation. Item

Biotech News

@FierceBiotech: AstraZeneca rolls the dice (again) on a failed cancer drug. More | Follow @FierceBiotech

@JohnCFierce: Be sure to check out our new weekly report: FierceDiagnostics | Follow @JohnCFierce

@RyanMFierce: Rare diabetes drug development startup Elcelyx Tx spins off nutraceutical assets into NaZura BioHealth. Release | Follow @RyanMFierce

@EmilyMFierce: Altered gene in mice extends lifespan by 20%. Story | Follow @EmilyMFierce

> Pursuing Alzheimer's, iPierian grabs $30M and spins off orphan drug biotech. More

> Transgene, Jennerex ponder fate of tumor-fighting virus after PhIIb failure. Story

> Rockwell Medical surges on more promising PhIII data for iron-delivery drug. Article

> BioMérieux to fork over $450M for Utah Dx outfit. News

Pharma News

@FiercePharma: India approves $1.6bn acquisition of Agila Specialties by Mylan. More | Follow @FiercePharma

@EricPFierce: ICYMI: Indian regulators find no serious problems at Wockhardt plant banned by FDA. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: How a peptide and a protein can help predict heart attack--and ease overcrowding in the emergency room. More from FierceBiomarkers | Follow @CarlyHFierce

> Onyx CEO Tony Coles will score $58M on Amgen deal. Story

> China talks about massive fines against GSK. More

> Eli Lilly's Alimta gains may cause Princeton pain. Article

Drug Delivery News

@MichaelGFierce: Self-powered nanomeds deliver bone-strengthening drugs. Article | Follow @MichaelGFierce

> Oramed submits pre-IND for oral exenatide Type 2 diabetes pill. More

> Meda buys Acton for $135M+, snags asthma inhaler. Item

> Google invests in oral drug delivery for insulin, other biologics. Story

> Nanosized DNA cages could deliver drugs with triggered release. Report

> Novan collects $7.8 million from gov to develop nitric oxide burn med. News

Diagnostics News

> BioFire Diagnostics keeps identity in $450M bioMérieux deal. Story

> Indian Dx giant emerges. Article

> ITC, Accumetrics merge with eye on global cardiovascular Dx. News

> Study: PET/MRI combo adds heft in cancer Dx. Report

> Cepheid wins key "moderate complexity" designation for combo TB test. More

> Siemens co-develops Alzheimer's blood test. Item

Biomarkers News

> Biomarker sorely needed for diagnosing chronic migraines. Story

> Heart attack biomarker could ease ER crowding. News

> Researchers zero in on biomarker for early diagnosis of ovarian cancer. Report

> Blood test flags organ transplant injury. Item

> Study: Protein may predict mesothelioma survival. More

> Biomarker test boosts prospects for Parkinson's prediction. Article

Suggested Articles

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,